Dual Action Antidepressants and Some Important Considerations
- 1 April 2003
- journal article
- research article
- Published by SAGE Publications in Australian & New Zealand Journal of Psychiatry
- Vol. 37 (2) , 190-195
- https://doi.org/10.1046/j.1440-1614.2003.01169.x
Abstract
Objective: To review controlled studies of long-term treatment and their side-effects with newer dual action antidepressants following an acute episode of major depression. Method: A literature review (MedLine) was undertaken and references were selected for their relevance and methodology in describing their contribution to the examination of our objective. Result and Conclusion: Three dual action antidepressants are identified: venlafaxine, mirtazapine and milnacipran. These are more effective and better tolerated than the older tricyclic antidepressants in the treatment of an acute episode of depression and in the prevention of relapse. They also offer advantages in that they lack autonomic side-effects of the tricyclics. However, sedation, nausea and sexual side-effects may occur with venlafaxine, and weight gain with mirtazapine.Keywords
This publication has 40 references indexed in Scilit:
- SNaRIs, NaSSAs, and NaRIs: new agents for the treatment of depressionThe Lancet, 2000
- A double-blind, randomized, placebo-controlled trial of once-daily venlafaxine extended release (XR) and fluoxetine for the treatment of depressionJournal of Affective Disorders, 1999
- Venlafaxine prevents recurrence of depressionEuropean Neuropsychopharmacology, 1998
- Blockade of 5‐Hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramineBritish Journal of Pharmacology, 1998
- SSRIs versus tricyclic antidepressants in depressed inpatients: A meta-analysis of efficacy and tolerabilityDepression and Anxiety, 1998
- Influence of biorhythm on reaction timesHuman Psychopharmacology: Clinical and Experimental, 1998
- A Risk-Benefit Assessment of Mirtazapine in the Treatment of DepressionDrug Safety, 1997
- MirtazapineCNS Drugs, 1996
- The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressantsJournal of Psychopharmacology, 1994
- Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1990